SUMMARY AND RECOMMENDATIONS Data integra*on, analysis, and - - PowerPoint PPT Presentation

summary and recommendations
SMART_READER_LITE
LIVE PREVIEW

SUMMARY AND RECOMMENDATIONS Data integra*on, analysis, and - - PowerPoint PPT Presentation

SUMMARY AND RECOMMENDATIONS Data integra*on, analysis, and interpreta*on of eight academic CLARITY-BPA studies JJ Heindel, S Belcher, JA Flaws, GS Prins, SM Ho, M Jiude, HB PaCsaul, W Ricke, CS Rosenfeld, AM Soto, FS vom Saal, RT Zoeller


slide-1
SLIDE 1

SUMMARY AND RECOMMENDATIONS

Data integra*on, analysis, and interpreta*on of eight academic CLARITY-BPA studies

JJ Heindel, S Belcher, JA Flaws, GS Prins, SM Ho, M Jiude, HB PaCsaul, W Ricke, CS Rosenfeld, AM Soto, FS vom Saal, RT Zoeller

Reproduc*ve Toxicology, July 2020

Jul 12:S0890-6238(20)30150-7.

doi: 10.1016/j.reprotox.2020.05.014

slide-2
SLIDE 2

CLARITY CLARITY-BP

  • BPA: Comb

mbined Guideline AND AND Academi mic studies to inform m risk assessme ment on BPA safety

Adapted from Pat Hunt

UR0GENITAL TRACT

GUIDELINE

Weight Histology

ACADEMIC

Urethral Colliculus enlargement Urethra morphometrics Body weight

THYROID

GUIDELINE

Weight Histology

ACADEMIC

Thyroid hormone levels Thyroid hormone brain endpoints

slide-3
SLIDE 3
  • High
  • Variation
  • experimental design
  • model
  • time points

REPRODUCIBILITY

CLARITY findings: conclusions remain the same

slide-4
SLIDE 4

SENSITIVITY

Brain Mammary Uterus, Ovary Heart Prostate Urethra

  • Reproducible endpoints
  • Far more sensitive

Ideal for future EDC testing paradigms

Affected organs:

slide-5
SLIDE 5
  • Significant adverse effects at the lowest dose 2.5 µg/kg BW
  • Consistent non-monotonic (i.e. non linear) responses
  • Integrative mixOmics analysis:

strong, complex inter-relationships

LOW-DOSE and NON-MONOTONIC EFFECTS

Strong evidence: low-dose effects are NOT spurious!

slide-6
SLIDE 6

ü Animals treated at FDA under GLP guidelines ü Investigators fully blinded ü Academic data locked before codes released

STUDY STRENGTHS

☞ All Academic studies meet requirements for

inclusion in risk assessment analysis

slide-7
SLIDE 7

Prior to CLARITY…

Guideline conclusions: only high doses are toxic

LOAEL = lowest observed adverse effect level; ATI = acceptable tolerable intake, aka RfD = Reference Dose NOAEL = no observed adverse effect level (calculaCon); MTD = maximum tolerable dose; 50,000 µg/kg 50 µg/kg/day

Adapted from Laura Vandenberg

slide-8
SLIDE 8

CLARITY-BPA…

New LOAEL is unequivocally 2.5 µg/kg … thus reference dose needs revisiting.

LOAEL = lowest observed adverse effect level; ATI = acceptable daily intake, aka RfD = Reference Dose NOAEL = no observed adverse effect level (calculaCon); MTD = maximum tolerable dose;

Adapted from Laura Vandenberg

2.5 µg/kg

?

slide-9
SLIDE 9

Data integra*on, analysis, and interpreta*on of eight academic CLARITY-BPA studies

JJ Heindel, S Belcher, JA Flaws, GS Prins, SM Ho, M Jiude, HB PaCsaul, W Ricke, CS Rosenfeld, AM Soto, FS vom Saal, RT Zoeller

Reproduc*ve Toxicology, July 2020

Jul 12:S0890-6238(20)30150-7. doi: 10.1016/j.reprotox.2020.05.014